Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

The Epoxide Hydratase Inducer Trans-Stilbene Oxide Shifts the Metabolic Epoxidation of Benzo(a)pyrene from the Bay- to the K-Region and Reduces Its Mutagenicity

M. BÜCKER, M. GOLAN, H. U. SCHMASSMANN, H. R. GLATT, P. STASIECKI and F. OESCH
Molecular Pharmacology September 1979, 16 (2) 656-666;
M. BÜCKER
Section on Biochemical Pharmacology, Institut of Pharmacology, University of Mainz, Obere Zahlbacher Straße 67, D-6500 Mainz, Federal Republic of Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. GOLAN
Section on Biochemical Pharmacology, Institut of Pharmacology, University of Mainz, Obere Zahlbacher Straße 67, D-6500 Mainz, Federal Republic of Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. U. SCHMASSMANN
Section on Biochemical Pharmacology, Institut of Pharmacology, University of Mainz, Obere Zahlbacher Straße 67, D-6500 Mainz, Federal Republic of Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. R. GLATT
Section on Biochemical Pharmacology, Institut of Pharmacology, University of Mainz, Obere Zahlbacher Straße 67, D-6500 Mainz, Federal Republic of Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. STASIECKI
Section on Biochemical Pharmacology, Institut of Pharmacology, University of Mainz, Obere Zahlbacher Straße 67, D-6500 Mainz, Federal Republic of Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. OESCH
Section on Biochemical Pharmacology, Institut of Pharmacology, University of Mainz, Obere Zahlbacher Straße 67, D-6500 Mainz, Federal Republic of Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Trans-stilbene oxide is a potent inducer of epoxide hydratase in rat liver which does not significantly alter cytochrome P-450 content or the specific activities of aminopyrine N-demethylase and benzo(a)pyrene monooxygenase measured by tritium release or fluorescence of phenols. Although three of these monooxygenase parameters are directly related to the metabolism of benzo(a)pyrene, we now report the surprising observation that the pattern of benzo(a)pyrene metabolites is substantially altered by trans-stilbene oxide treatment. The formation of metabolites oxidized at the 7,8,9,10-benzo ring was decreased by a factor of 3 whereas the formation of 4,5-dihydroxy-4,5-dihydrobenzo(a)pyrene was increased 6-fold. The ratio between 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene (dihydrodiol bay region epoxide precursor) and 4,5-dihydroxy-4,5-dihydrobenzo(a)pyrene was decreased more than 20-fold. We also found that ethoxycoumarin O-deethylase activity was increased 2.5-fold and preferentially inhibited by metyrapone. These marked effects on monooxygenase activities severely limit the selectivity of trans-stilbene oxide as epoxide hydratase inducer. The mutagenicity with his- Salmonella typhimurium was up to 10 times lower when benzo(a)pyrene was activated by microsomes or postmitochondrial fraction from trans-stilbene oxide-treated as compared to control animals. Two factors contribute to this protection: (1) A decreased formation of mutagenic dihydrodiol epoxides at the 7,8,9,10-benzo ring due to the shift of the metabolism to the 4,5-position, (2) a more efficient inactivation of the mutagenic benzo(a)pyrene 4,5-oxide due to the induction of epoxide hydratase. Thus trans-stilbene oxide causes two effects in the rat liver, which can synergistically reduce the harmful effects of benzo(a)pyrene. This study shows that benzo(a)pyrene metabolite patterns and consequent biological effects can be substantially altered without any significant change in the fluorescence intensity of the alkali extractable metabolites, the so called AHH (aryl hydrocarbon hydroxylase) activity.

ACKNOWLEDGMENT The authors thank Dr. K. L. Platt for the preparation of ethoxycoumarin.

  • Copyright © 1979 by Academic Press, Inc.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 16, Issue 2
1 Sep 1979
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The Epoxide Hydratase Inducer Trans-Stilbene Oxide Shifts the Metabolic Epoxidation of Benzo(a)pyrene from the Bay- to the K-Region and Reduces Its Mutagenicity
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

The Epoxide Hydratase Inducer Trans-Stilbene Oxide Shifts the Metabolic Epoxidation of Benzo(a)pyrene from the Bay- to the K-Region and Reduces Its Mutagenicity

M. BÜCKER, M. GOLAN, H. U. SCHMASSMANN, H. R. GLATT, P. STASIECKI and F. OESCH
Molecular Pharmacology September 1, 1979, 16 (2) 656-666;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

The Epoxide Hydratase Inducer Trans-Stilbene Oxide Shifts the Metabolic Epoxidation of Benzo(a)pyrene from the Bay- to the K-Region and Reduces Its Mutagenicity

M. BÜCKER, M. GOLAN, H. U. SCHMASSMANN, H. R. GLATT, P. STASIECKI and F. OESCH
Molecular Pharmacology September 1, 1979, 16 (2) 656-666;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Cysteine151 in Keap1 Drives CDDO-Me Pharmacodynamic Action
  • Allosteric Modulation of Metabotropic Glutamate Receptor 1
  • Mechanism of Selective Action of Paraherquamide A
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics